|
■FEATURE ARTICLE
|
|
|
|
|
●Comments on Drug-Related Provisions in the Fourth Revision of the Patent Law
|
Cheng Yongshun and Wu Lijuan
|
2021.1
|
8
|
|
●Application of Behaviour Preservation in International IP Parallel Litigation
— Comments on Huawei v. Conversant
|
Zhang Guangliang
|
2021.2
|
8
|
|
●Probe into Anti-Suit Injunction in China
|
Liao Jibo
|
2021.2
|
20
|
|
●Studies on Issues Relating to Patent Validity under Patent Linkage System
|
He Wei and Ren Xiaolan
|
2021.2
|
34
|
|
●On Rules for Examining Partial Designs
|
Li Yonghong
|
2021.3
|
8
|
|
●New Progress of Beijing IP Court in Facilitating the Filing of Foreign-Related Administrative IP Lawsuits
|
Jin Xuejun
|
2021.4
|
8
|
|
|
|
|
|
|
■PATENT
|
|
|
|
|
●Application of Inventive Concept in Inventive Step Assessment Based on the “Restaurant System” Case
|
Liu Liwei
|
2021.1
|
19
|
|
●Patent Portfolio Consciousness and Divisional Application
— Based on the First Case Tried at the IP Court of the Supreme People's Court
|
Jia Jingdong
|
2021.1
|
32
|
|
●Brief Discussion on Patent Protection Strategies for GUI Designs
|
Ning Xiaojun
|
2021.1
|
44
|
|
●On Overall Consideration Principle for Assessing Inventive Step of Business Method Patent
|
He Jun
|
2021.2
|
48
|
|
●On “Omission of an Element” in Inventive Step Assessment
|
Du Heng
|
2021.2
|
58
|
|
●Probe into Intervening Rights in Patent Infringement Defense
|
Yao Jianjun
|
2021.3
|
20
|
|
●Reflections on the Effective Date of the Invalidation Decision
|
Yi Jun and Shi Xin
|
2021.3
|
31
|
|
●On Determination of Drawing Disclosure
|
Liu Ping
|
2021.3
|
43
|
|
●Identification of Average Consumers in Component Design
|
Zhang Di
|
2021.3
|
53
|
|
●Specific Criteria for Applying the Doctrine of Estoppel in Patent Infringement Proceedings
|
Shang Jiangang
|
2021.4
|
22
|
|
●Theoretical and Practical Research on Prohibition of Double Patenting
|
Wang Ying and Li Yue
|
2021.4
|
39
|
|
●Judgment on Conflict Between Design Patent and Prior Trademark
|
Gao Guilian and Zhong Hua
|
2021.4
|
53
|
|
●On “Components” as Subject Matter Eligible for Utility Model Protection
|
Bi Yajing
|
2021.4
|
64
|
|
|
|
|
|
|
■TRADEMARK
|
|
|
|
|
●Registered Planar Figurative Trademark Should Not Be a Suitable Route for Protection of Product Appearance
|
Zhang Weijun and Zhaoyang
|
2021.3
|
66
|
|
●Probe into the Relationship Between Sales Promotion for Others and Retail & Wholesale
|
Du Ying and Deng Sijie
|
2021.4
|
77
|
|
|
|
|
|
|
■COPYRIGHT
|
|
|
|
|
●Decade-Long Revision of the New Copyright Law
|
Zhang Hongbo
|
2021.2
|
68
|
|
|
|
|
|
|
■IP SYSTEM
|
|
|
|
|
●Studies on Supplementary Protection Certificate System in the UK and Typical Cases Thereof
|
Liu Rui and Liu Yang
|
2021.2
|
84
|
|
|
|
|
|
|
■PERSPECTIVES
|
|
|
|
|
●A Study on Domestic Priority Rules
|
Li Yonghong
|
2021.1
|
55
|
|
●Meaning of “Other Works”
|
Wei Zhi
|
2021.2
|
96
|
|
●Calm Reflections on Construction of Anti-Suit Injunction Rules in SEP Disputes
|
Li Yang
|
2021.3
|
84
|
|
●Reflections on Domestic Priority
— Comments on the Legislative Defect of Rule 32 of the Implementing Regulations of the Patent Law
|
Wei Zheng
|
2021.4
|
91
|
|
|
|
|
|
|
■CASE STUDY
|
|
|
|
|
●“Interpretation” and “Explanation” of Claim Features
|
Zhang Rongyan
|
2021.1
|
68
|
|
|
|
|
|
|
■STATUTES & RULES
|
|
|
|
|
●Patent Law of the People's Republic of China
|
|
2021.1
|
82
|
|
●Provisions of the Supreme People's Court on Evidence in Intellectual Property Civil Litigation
|
|
2021.1
|
93
|
|
●Measures for the Implementation of the Early Resolution Mechanism for Drug Patent Disputes
(Trial Implementation) and Its Policy Interpretation
|
|
2021.4
|
99
|
|
|
|
|
|
|
■IP Event Witness
|
|
|
|
|
●The 12th China International Patent Fair cum the 21st WIPO-CNIPA Award for
Chinese Outstanding Patented Inventions
|
|
2021.1
|
2
|
|
●Comments on the Fourth Revision of the Patent Law
|
Carissa Huihui Li
|
2021.1
|
100
|
|
●The 5th China Pharma IP Summit
|
|
2021.1
|
105
|
|
●CNIPA Issued the 2020 IPR Statistics
|
|
2021.2
|
2
|
|
●China Took the Lead in PCT Applications
|
|
2021.2
|
2
|
|
●Judgment Essentials (2020) Released by IP Court of the Supreme People's Court (I)
|
|
2021.2
|
101
|
|
●CNIPA Holds the 2021 Open Day Event
|
|
2021.3
|
2
|
|
●Global Medical Device Intellectual Property Summit
|
|
2021.3
|
2
|
|
●Center for Drug Evaluation Opens Patent Information Listing Platform for Public Testing
|
|
2021.3
|
94
|
|
●Judgment Essentials (2020) Released by IP Court of the Supreme People's Court (II)
|
|
2021.3
|
99
|
|
●Interim Measures for Handling Examination Matters Concerning the Implementation of the Revised Patent Law
|
|
2021.3
|
104
|
|
●Symposium on Issues Relevant to Legal Protection of Trade Secrets
|
|
2021.4
|
2
|